Buscar en
Acta Otorrinolaringológica Española
Toda la web
Inicio Acta Otorrinolaringológica Española Contralateral sensorineural hearing loss after vestibular schwannoma surgery
Journal Information
Vol. 70. Issue 3.
Pages 165-168 (May - June 2019)
Share
Share
Download PDF
More article options
Visits
53
Vol. 70. Issue 3.
Pages 165-168 (May - June 2019)
Brief communication
Contralateral sensorineural hearing loss after vestibular schwannoma surgery
Hipoacusia neurosensorial contralateral tras cirugía de schwannoma vestibular
Visits
53
Patricia García-Cabo1,
Corresponding author
patriciagcabo@gmail.com

Corresponding author.
, Fernando Rivas1, Fernando López, Andrés Coca, José Luis Llorente, Justo R. Gómez
Department of Otorhinolaryngology and Head and Neck Surgery, Hospital Universitario Central de Asturias, Oviedo, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (1)
Table 1. Patients with contralateral hearing loss after acoustic neuroma surgery.
Abstract
Introduction

Contralateral sensorineural hearing loss (CSNHL) after vestibular schwannoma (VS) is a severe complication, especially in those cases in which hearing preservation in the operated side was not possible. There are several theories that attempt to explain this issue, but there is no established guideline of treatment.

Material and methods

We report 4 patients treated in our institution who developed a severe CSNHL after surgery.

Results

Of the 185 cases of VS treated with surgery, 4 patients (2.2%) developed a CSNHL after VS surgery. After medical treatment, partial recovery of hearing occurred in one patient the other 3 patients presented a well-established severe SNHL.

Conclusions

Established treatment guidelines do not exist, but the use of high doses of corticosteroids has been recommended and cochlear implant in cases with no recovery and complete hearing loss may be useful.

Keywords:
Contralateral hearing loss
Vestibular schwannoma
Surgery
Complication
Resumen
Introducción

La hipoacusia neurosensorial contralateral (HNSC) tras cirugía de schwannoma vestibular (SV) es una complicación grave, especialmente en aquellos casos en los que la preservación de la audición del lado intervenido no fue posible. Existen varias teorías que intentan explicar este problema, pero no existe una guía de tratamiento en estos casos.

Material y métodos

Presentamos los casos de 4 pacientes tratados en nuestro hospital que desarrollaron una HNSC severa tras cirugía de SV.

Resultados

De los 185 casos de SV tratados con cirugía, 4 pacientes (2,2%) desarrollaron una HNSC después de la cirugía. Tras el tratamiento médico se produjo recuperación parcial de la audición en un paciente, los otros 3 pacientes presentaron una HNS severa.

Conclusiones

No existen guías de tratamiento, pero se recomienda el uso de altas dosis de corticosteroides y el implante coclear en casos sin recuperación y pérdida completa de la audición.

Palabras clave:
Hipoacusia contralateral
Schwannoma vestibular
Cirugía
Complicación

Article

These are the options to access the full texts of the publication Acta Otorrinolaringológica Española
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Acta Otorrinolaringológica Española

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.otorri.2018.02.004
No mostrar más